Northwest Bancshares (NASDAQ:NWBI) Surprises With Q2 CY2026 Sales

Northwest Bancshares (NASDAQ: NWBI) reported Q2 CY2026 results with sales up 20.5% year over year to $181.2 million, topping Wall Street revenue estimates by 1.2%, according to the company. Non-GAAP profit was $0.37 per share, about 10% above analysts’ consensus. The stock was flat at $15.42 after the release.

Original reporting
Published Jul 27, 2026, 9:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 27, 2026, 10:09 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Northwest Bancshares (NASDAQ:NWBI) Surprises With Q2 CY2026 Sales — source image
Decision brief

The 30-second read

$NWBIBullishMed
01

Why it matters

A reported beat on revenue and non-GAAP EPS, alongside management claims of strong loan growth and lower deposit costs, can support valuation and near-term positioning for NWBI, but the lack of credit and forward guidance limits conviction.

02

Market read

Traders can reassess NWBI’s near-term earnings power and NII drivers after the reported beat, but should verify credit metrics and any forward outlook not included here.

03

What to watch

No details are provided on credit quality, NPL trends, net charge-offs, or deposit mix, which can quickly reverse optimism in regional banks.

Relevance 7/10Novelty 6/10Timing: after-hours/next-session reaction to Q2 CY2026 results

Background

The piece frames Northwest Bancshares’s Q2 CY2026 performance versus Wall Street expectations and discusses longer-term revenue and tangible book value trends.

Company-level read

Ticker impact

$NWBIBullishMedium confidence
Context

Northwest Bancshares reported Q2 CY2026 revenue up 20.5% to $181.2 million and non-GAAP EPS of $0.37, beating consensus.

Expected impact

Mildly positive bias for the stock versus peers, with follow-through dependent on whether the market focuses on NII and deposit-cost trajectory.

Evidence & confidence

The article provides specific quarterly datapoints (revenue, EPS) and management drivers (C&I loan growth, lower deposit costs) but includes no new forward guidance or balance-sheet stress details.

Market effects

Regional bank read-through may improve if investors view the deposit-cost trend and loan growth as durable drivers of net interest income.

Potential modest sentiment lift for US regional banks, especially those with similar deposit franchises and C&I exposure.

Limited direct global impact; primarily a US rates and regional banking sentiment signal.

Counterpoint

The article notes revenue quality concerns (outlier quarters) and that net interest income dominates revenue, so results may be more rates-sensitive than the narrative suggests.

Key entities

  • Northwest Bancshares

    Reported Q2 CY2026 revenue of $181.2 million (+20.5% YoY) and non-GAAP EPS of $0.37 (+10% vs consensus), with commentary on loan growth and deposit-cost improvement.

Related articles

$NWBIMed

Northwest Bancshares, Inc. (NWBI): Results of Operations and Financial Condition

Northwest Bancshares, Inc. (NWBI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a2026-06x30nwbi8ker.htm EX-99.1 Document EXHIBIT 99.1 PRESS RELEASE OF NORTHWEST BANCSHARES, INC. EARNINGS RELEASE FOR IMMEDIATE RELEASE Northwest Bancshares, Inc. Announces Record Second Quarter 2026 GAAP net income of $54 million, or $0.36 per diluted share Adjusted d

$WHRMed

Whirlpool Q2 Earnings Call Highlights

Whirlpool (NYSE:WHR) reported Q2 earnings call updates. North America industry demand fell 3.4% YoY, but Whirlpool said it held market share. The company raised promotional pricing by over 10% in late April and expects further margin improvement in Q3. It targets $150M cost reductions in 2026, including $60M automation, and guided FY revenue up ~1.5% and FCF of ~$300M.

$WATMedAI 8/10

Waters Q2 Earnings Call Highlights

Waters (NYSE:WAT) reported Q2 updates from its earnings call. Materials Science Division revenue rose to $87M. Biosciences and Diagnostic Solutions acquired from BD generated $817M revenue. Waters raised FY organic constant-currency growth outlook to 7% to 9%, projecting FY reported revenue of $3.370B to $3.431B and adjusted EPS of $14.45 to $14.65.

$VTEXMedAI 8/10

VTEX Q2 Earnings Call Highlights

VTEX (NYSE:VTEX) reported Q2 margin and cash flow improvement and guided for Q3 and full-year low-single-digit FX-neutral subscription revenue growth and low-20% non-GAAP operating and free cash flow margins. Q2 non-GAAP subscription gross margin rose to 81.8%. Free cash flow rose 79% to $12.7M. VTEX repurchased 6.2M shares at $3.76.

$WMedAI 8/10

Wayfair Q2 Earnings Call Highlights

Wayfair (NYSE:W) said Q2 new-order growth accelerated for a fourth straight quarter to a post-COVID high, citing U.S. gains from pricing, selection, delivery speed and availability, plus initiatives like Wayfair Rewards and stores. Q3 revenue growth is forecast at high-single digits. Perigold sales grew over 35% YoY and exceeded $400M annual. Q2 gross margin was 30.0%, adjusted EBITDA $242M, and free cash flow $301M. The company issued $400M notes to redeem 2028 converts.

$VYXMed

NCR Voyix Q2 Earnings Call Highlights

NCR Voyix (NYSE:VYX) reported Q2 progress on enterprise platform transformations, including a remote Voyix POS installation for a large European grocery retailer completed in about half the usual time. Retail signed 40+ customers; retail revenue fell 20% to $365M due to hardware transition, but adjusted EBITDA rose 20% to $97M. Restaurant revenue fell 23% to $158M. Non-GAAP EPS was $0.17. Full-year 2026 outlook maintained: revenue $2.188B-$2.303B, adj EBITDA $432M-$447M, EPS $0.89-$0.92.